Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

This study has been completed.
Cross Cancer Institute
Information provided by (Responsible Party):
AHS Cancer Control Alberta Identifier:
First received: April 11, 2006
Last updated: February 23, 2016
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: March 2006
  Estimated Primary Completion Date: No date given